Cargando…

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Koning, Rutger, Bastard, Paul, Casanova, Jean-Laurent, Brouwer, Matthijs C., van de Beek, Diederik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034036/ https://www.ncbi.nlm.nih.gov/pubmed/33835207 http://dx.doi.org/10.1007/s00134-021-06392-4

Ejemplares similares

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
por: Bastard, Paul, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality
por: Troya, Jesús, et al.
Publicado: (2022)

Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2021)

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022)

Type I interferons and SARS-CoV-2: from cells to organisms
por: Bastard, Paul, et al.
Publicado: (2022)

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
por: de Prost, Nicolas, et al.
Publicado: (2021)

Human autoantibodies underlying infectious diseases
por: Puel, Anne, et al.
Publicado: (2022)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19
por: Eto, Shohei, et al.
Publicado: (2022)

Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021)

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients
por: Goncalves, David, et al.
Publicado: (2021)

Complement inhibition in severe COVID-19 – Blocking C5a seems to be key
por: Lim, Endry H.T., et al.
Publicado: (2021)

450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient
por: Yee, Debra, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
por: Troya, Jesús, et al.
Publicado: (2021)

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
por: van der Wijst, Monique G. P., et al.
Publicado: (2021)

Adjunctive dexamethasone treatment in adults with listeria monocytogenes meningitis: a prospective nationwide cohort study
por: Brouwer, Matthijs C., et al.
Publicado: (2023)

Chest computed tomography characteristics of critically ill COVID-19 patients with auto-antibodies against type I interferons
por: Rapnouil, Baptiste Lafont, et al.
Publicado: (2023)

Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Auto-anticorps anti-interférons de type I et COVID-19 sévère
por: Bastard, Paul, et al.
Publicado: (2021)

Targeting the complement system in bacterial meningitis
por: Koelman, Diederik L H, et al.
Publicado: (2019)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
por: Valour, Florent, et al.
Publicado: (2016)

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
por: Solanich, Xavier, et al.
Publicado: (2021)

Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis
por: Fritz, Daan, et al.
Publicado: (2016)

Host genetic variability and pneumococcal disease: a systematic review and meta-analysis
por: Kloek, Anne T., et al.
Publicado: (2019)

Suspected Central Nervous System Infections in HIV-Infected Adults
por: Sheybani, Fereshte, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in patients with critical influenza pneumonia
por: Zhang, Qian, et al.
Publicado: (2022)

Sex‐based differences in the response to dexamethasone in bacterial meningitis: Analysis of the European dexamethasone in adulthood bacterial meningitis study
por: Dias, Sara P., et al.
Publicado: (2020)

Clinical characteristics and outcome of hydrocephalus in neurosarcoidosis: a retrospective cohort study and review of the literature
por: ten Dam, Leroy, et al.
Publicado: (2021)

Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021)

Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection?
por: Kacar, Mark, et al.
Publicado: (2021)

Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
por: Burbelo, Peter D., et al.
Publicado: (2019)

Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis
por: Wang, Xi, et al.
Publicado: (2023)

What’s new in bacterial meningitis
por: Brouwer, Matthijs C., et al.
Publicado: (2016)

Whole genome sequencing identifies variants associated with sarcoidosis in a family with a high prevalence of sarcoidosis
por: Fritz, Daan, et al.
Publicado: (2021)

Autoantibodies to Interferons in Infectious Diseases
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2m8si82mr1b7c59kfbmfurh463